NCT00936117View on ClinicalTrials.gov

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

LeukemiaFungal Infection

Interventions

DRUG

Posaconazole

200 mg (liquid) by mouth 3 times per day.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER